+
Open data
-
Basic information
| Entry | Database: PDB / ID: 11rm | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | Cryo-EM structure of human exportin-1 conjugated with FR-027* | ||||||||||||||||||||||||
Components | Exportin-1 | ||||||||||||||||||||||||
Keywords | PROTEIN TRANSPORT / nuclear transport / inhibitor | ||||||||||||||||||||||||
| Function / homology | Function and homology informationcellular response to triglyceride / cellular response to salt / HuR (ELAVL1) binds and stabilizes mRNA / annulate lamellae / nuclear export signal receptor activity / regulation of proteasomal ubiquitin-dependent protein catabolic process / Rev-mediated nuclear export of HIV RNA / NEP/NS2 Interacts with the Cellular Export Machinery / nucleocytoplasmic transport / Maturation of hRSV A proteins ...cellular response to triglyceride / cellular response to salt / HuR (ELAVL1) binds and stabilizes mRNA / annulate lamellae / nuclear export signal receptor activity / regulation of proteasomal ubiquitin-dependent protein catabolic process / Rev-mediated nuclear export of HIV RNA / NEP/NS2 Interacts with the Cellular Export Machinery / nucleocytoplasmic transport / Maturation of hRSV A proteins / ribosomal large subunit export from nucleus / Estrogen-dependent nuclear events downstream of ESR-membrane signaling / protein export from nucleus / Cajal body / ribosomal subunit export from nucleus / mRNA export from nucleus / Cyclin A/B1/B2 associated events during G2/M transition / NPAS4 regulates expression of target genes / ribosomal small subunit export from nucleus / Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal / Transcriptional and post-translational regulation of MITF-M expression and activity / Mitotic Prometaphase / EML4 and NUDC in mitotic spindle formation / Resolution of Sister Chromatid Cohesion / Downregulation of TGF-beta receptor signaling / Heme signaling / Maturation of DENV proteins / RHO GTPases Activate Formins / Deactivation of the beta-catenin transactivating complex / MAPK6/MAPK4 signaling / small GTPase binding / kinetochore / Separation of Sister Chromatids / nuclear envelope / ribosome biogenesis / DNA-binding transcription factor binding / response to xenobiotic stimulus / ribonucleoprotein complex / protein domain specific binding / nucleolus / negative regulation of transcription by RNA polymerase II / protein-containing complex / nucleoplasm / membrane / cytosol / cytoplasm Similarity search - Function | ||||||||||||||||||||||||
| Biological species | Homo sapiens (human) | ||||||||||||||||||||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 2.95 Å | ||||||||||||||||||||||||
Authors | Wing, C.E. / Fung, H.Y.J. / Chook, Y.M. | ||||||||||||||||||||||||
| Funding support | United States, 5items
| ||||||||||||||||||||||||
Citation | Journal: Nat Commun / Year: 2026Title: Preclinical characterization of a reversible XPO1 inhibitor for cancer therapy. Authors: Janne Van Hauwenhuyse / Felien Reniers / Leentje Persoons / Sam Noppen / Casey E Wing / Ashley B Niesman / Ho Yee Joyce Fung / Els Vanstreels / Maarten Jacquemyn / Eline Boel / Ann ...Authors: Janne Van Hauwenhuyse / Felien Reniers / Leentje Persoons / Sam Noppen / Casey E Wing / Ashley B Niesman / Ho Yee Joyce Fung / Els Vanstreels / Maarten Jacquemyn / Eline Boel / Ann Vankerckhoven / Yani Berckmans / Bert Kwanten / An Coosemans / Guy Van den Mooter / Yuh Min Chook / Wim Dehaen / Dirk Daelemans / ![]() Abstract: Exportin 1 (XPO1/CRM1) is a clinically validated anticancer target whose inhibition blocks nuclear export and promotes cancer cell apoptosis. Current XPO1 inhibitors rely on covalent Michael addition ...Exportin 1 (XPO1/CRM1) is a clinically validated anticancer target whose inhibition blocks nuclear export and promotes cancer cell apoptosis. Current XPO1 inhibitors rely on covalent Michael addition to Cys528 in the nuclear export signal binding groove of XPO1. Here, we describe a novel XPO1 inhibitor, FR-027, that targets Cys528 through nucleophilic aromatic substitution. In contrast to clinical-stage XPO1 inhibitors selinexor and eltanexor, FR-027 acts reversibly and does not promote XPO1 protein degradation. Structural analysis of the XPO1-FR-027 complex reveals covalent modification of Cys528 and a closed-groove conformation that prevents degradation. FR-027 demonstrates potent on-target activity across multiple cancer cell types and delays disease progression while extending overall survival in xenograft and syngeneic models, including intracranial tumors. Notably, FR-027 does not induce significant thrombocytopenia, lymphopenia, or neutropenia in heavily treated mice. These findings underscore the distinct molecular and pharmacological properties of FR-027 and support its further evaluation for clinical development in diseases with significant unmet medical needs. | ||||||||||||||||||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 11rm.cif.gz | 310.5 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb11rm.ent.gz | Display | PDB format | |
| PDBx/mmJSON format | 11rm.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/1r/11rm ftp://data.pdbj.org/pub/pdb/validation_reports/1r/11rm | HTTPS FTP |
|---|
-Related structure data
| Related structure data | ![]() 75979MC M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
| #1: Protein | Mass: 123662.484 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Details: GS remaining after TEV cleavage, covalently bound to FR-027* at C528 Source: (gene. exp.) Homo sapiens (human) / Gene: XPO1, CRM1 / Plasmid: pGEX4TT3 / Production host: ![]() |
|---|---|
| #2: Chemical | ChemComp-A1DBJ / Mass: 127.101 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: C4H5N3O2 |
| Has ligand of interest | Y |
| Has protein modification | Y |
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component | Name: Full-length human XPO1 conjugated to FR-027* / Type: COMPLEX / Entity ID: #1 / Source: RECOMBINANT | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular weight | Value: 0.124 MDa / Experimental value: NO | ||||||||||||||||||||||||||||||
| Source (natural) | Organism: Homo sapiens (human) | ||||||||||||||||||||||||||||||
| Source (recombinant) | Organism: ![]() | ||||||||||||||||||||||||||||||
| Buffer solution | pH: 7.4 Details: 20 mM HEPES pH 7.4, 150 mM NaCl, 2 mM Mg(OAc)2, 2 mM TCEP, 0.025% Tyloxapol | ||||||||||||||||||||||||||||||
| Buffer component |
| ||||||||||||||||||||||||||||||
| Specimen | Conc.: 3 mg/ml / Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES | ||||||||||||||||||||||||||||||
| Specimen support | Grid material: COPPER / Grid mesh size: 300 divisions/in. / Grid type: Quantifoil R1.2/1.3 | ||||||||||||||||||||||||||||||
| Vitrification | Instrument: FEI VITROBOT MARK IV / Cryogen name: ETHANE / Humidity: 95 % / Chamber temperature: 280 K |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: TFS KRIOS |
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: FLOOD BEAM |
| Electron lens | Mode: BRIGHT FIELD / Nominal magnification: 165000 X / Nominal defocus max: 2400 nm / Nominal defocus min: 900 nm / Cs: 2.7 mm |
| Specimen holder | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER |
| Image recording | Electron dose: 50 e/Å2 / Film or detector model: FEI FALCON IV (4k x 4k) / Num. of grids imaged: 1 / Num. of real images: 25729 |
| EM imaging optics | Energyfilter name: TFS Selectris X / Energyfilter slit width: 10 eV |
-
Processing
| EM software |
| ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||||||||||||||||||||||||||
| Particle selection | Num. of particles selected: 1867386 / Details: blob picking followed by Topaz picking | ||||||||||||||||||||||||||||||||||||||||||||||||
| 3D reconstruction | Resolution: 2.95 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 630291 / Symmetry type: POINT | ||||||||||||||||||||||||||||||||||||||||||||||||
| Atomic model building | B value: 179.36 / Protocol: OTHER / Space: REAL Details: Initial models were docked into maps using UCSF ChimeraX then manually built using Isolde and Coot and refined in PHENIX | ||||||||||||||||||||||||||||||||||||||||||||||||
| Atomic model building | PDB-ID: 9OG9 Pdb chain-ID: A / Accession code: 9OG9 / Details: starting model for XPO1 / Source name: PDB / Type: experimental model | ||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement | Highest resolution: 2.95 Å / Cross valid method: NONE Stereochemistry target values: REAL-SPACE (WEIGHTED MAP SUM AT ATOM CENTERS) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints |
|
Movie
Controller
About Yorodumi




Homo sapiens (human)
United States, 5items
Citation

PDBj












FIELD EMISSION GUN
